Skip to content

Effect of Basti Karma (enema) Hapushadi Yapana and Kashmaryadi Kashaya (oral medication) Vatarakta Gout.

A Comparative Study of Hapushadi Yapana Basti And Kashmaryadi Kashaya in Vatarakta with special reference to Gout. - HAPUKASHVAT

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056955
Enrollment
60
Registered
2023-08-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

Government PG Ayurveda College and Hospital Varanasi UP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 20-60years. 2.Sex: Both male and female. 3.The patients of Vatarakta having serum uric acid > 7mg/dl in males and >6mg?dl in females and all 3 essential symptoms with or without non essential symptomatology. 4.Symptoms of Vatarakta(According to Ch.Chi.29/20,21,22,23)

Exclusion criteria

Exclusion criteria: Patients below 20 years and above 60 years of age. Patients having serum uric acid >10.3mg/dl in female s and >11.6mg/dl in males. Complicated cases of Vatarakta with other systemic disorders ,renal diseases,like Uncontrolled Diabetes, uncontrolled thyroid disorder,renal diseases,hepatic diseases,cardic patients,psoriatic arthritis etc. Complicated cases of vatarakta by its updravas like Hikka,Moorchha,Moha,Visarpa,mansa-koyh,angulivakrata etc. Complicated cases of gout with chronic joint deformity,marked dysfunction,discharging tophi,etc. Pregnancy and lactation. Rheumatoid Arthritis,Osteoarthritis,Psoriatic arthritis,known cases of SLE,Renal diseases,Hepatic diseases,patients on anti-tubercular drugs,cardiac patients on low doses of aspirin.

Design outcomes

Primary

MeasureTime frame
Relief in sign and symptomsTimepoint: 15 days

Secondary

MeasureTime frame
To increase Quality of lifeTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Ritu Singh

GOVERNMENT P.G.AYURVEDA COLLEGE AND HOSPITAL,VARANASI

rachananigam19@gmail.com8948732899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026